A closer look at the science of intensive neurorehabilitation and medication optimization, illustrative patient outcomes, the movement-disorder specialists involved, and how a program cycle is structured.
Cuba's Parkinson's program combines intensive therapy with careful medication management and biotechnology. These summaries outline the scientific basis — individual outcomes vary.
High-volume, multidisciplinary therapy (4–6 hours daily across physical, occupational, and speech therapy) is associated with gains in motor scales such as the UPDRS and in functional independence measures.
CIREN outcome reports; movement-disorder rehabilitation literature.
Careful titration of dopaminergic therapy — timing, formulation, and dose — can reduce motor fluctuations and dyskinesia while maximizing 'on' time, especially under specialist supervision.
International Parkinson's treatment guidelines.
Cuban biotech options, including NeuralCIM® (NeuroEPO), are under study for potential disease-modifying effects aimed at slowing neuronal loss — administered under medical monitoring.
Center of Molecular Immunology (CIM), Havana.
Addressing depression, sleep disruption, and cognitive change — not only tremor and rigidity — is linked to better quality of life for both patients and caregivers.
Parkinson's non-motor symptom consensus.
Educational summary only. Treatment eligibility is determined by specialist review of each patient's records. Outcomes vary and are not guaranteed.
Composite cases reflecting typical patient profiles and reported experiences. Names and details have been changed to protect privacy.
"I hadn't walked without freezing for two years. After three weeks of daily therapy I crossed my living room without stopping. My wife cried."
J. Martínez, 61
Parkinson's, Hoehn & Yahr stage 2
Reduced tremor; improved gait after 4-week cycle
"The pharmacist sat with me for an hour and rebuilt my medication schedule. The difference in my good hours was immediate — and they taught my US doctor why."
P. Carter, 58
Parkinson's with motor fluctuations
Smoother 'on' time after medication tuning
"I was afraid to leave the house. The balance training gave me back my independence — and the remote check-ins kept me honest once I was home."
H. Castillo, 67
Parkinson's, postural instability
Fewer falls; restored confidence in walking
Composite illustrative cases based on typical patient profiles. Names and details have been changed to protect privacy. Individual results vary.
A coordinated team of movement-disorder neurologists, therapists, and a clinical pharmacist — working under one plan, not in separate silos.
Movement-Disorder Neurologist
Diagnoses, stages (UPDRS), and directs the personalized plan — the clinical lead for each Parkinson's patient.
Physical Therapist
Delivers intensive daily gait, balance, and strength training to restore functional mobility and reduce fall risk.
Occupational Therapist
Retrains fine motor control and daily-living skills to preserve independence at home.
Clinical Pharmacist
Tunes levodopa and dopaminergic therapy to maximize benefit and minimize dyskinesia and side effects.
Speech-Language Therapist
Addresses hypophonia, articulation, and swallowing difficulties common in Parkinson's.
Neuropsychologist
Supports the cognitive and emotional changes — depression, anxiety, executive change — that accompany the disease.
Every plan is individualized after specialist review. These tiers describe typical pathways — final scope and cost are confirmed after records evaluation.
Records review · 48 hours
No charge
4 weeks on-site
Core program
6–8 weeks on-site
Intensive track
Pricing varies with clinical complexity, program length, and required services. A written estimate is provided after the free remote records review. NeuroCuba does not guarantee specific outcomes, and all treatment is subject to specialist approval.
Submit medical records for a free remote review, or speak with an international care coordinator about the Parkinson's program.